Clinical Trials in Michigan

Showing 7881-7900 of 16,154 trials

MyT1DHero: an mHealth Intervention for Type 1 Diabetes

NCT03521362

The overall objective of the proposed research is to improve HbA1c, adherence to treatment plans, and family communication surrounding adolescents' self-management of T1D. The investigators will test the efficacy of the MyT1DHero app against an attention control group. This will allow investigators to better understand the health and psychosocial improvements being made through the app.

Type1diabetes

Michigan State University33 participantsStarted Jan 2019

East Lansing, Michigan, United States

COMPLETEDPhase 341 miles

An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis

NCT01885078

The purpose of this study is to investigate the long-term safety and any side effects of baricitinib in participants who have completed a previous baricitinib rheumatoid arthritis study. The study provides 7 years of additional treatment with baricitinib.

Rheumatoid Arthritis

Eli Lilly and Company2,877 participantsStarted Jun 2013

Glendale, Arizona, United States • Mesa, Arizona, United States • Peoria, Arizona, United States +405 more locations

MyT1DHero: an mHealth Intervention for Type 1 Diabetes

An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis

Find Trials by Condition in Michigan

One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity

Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis

Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)

A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)

Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)

A Study of RG-012 in Subjects With Alport Syndrome

Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma

Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL

Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)

Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease

Reconnecting: Improving Interoception to Reduce Suicidal Ideation in the Military

Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease

A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma

A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period

Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation

A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease

Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.